GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coral Laboratories Ltd (BOM:524506) » Definitions » Gross Profit

Coral Laboratories (BOM:524506) Gross Profit : ₹603 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Coral Laboratories Gross Profit?

Coral Laboratories's gross profit for the three months ended in Dec. 2024 was ₹135 Mil. Coral Laboratories's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was ₹603 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Coral Laboratories's gross profit for the three months ended in Dec. 2024 was ₹135 Mil. Coral Laboratories's Revenue for the three months ended in Dec. 2024 was ₹230 Mil. Therefore, Coral Laboratories's Gross Margin % for the quarter that ended in Dec. 2024 was 58.82%.

Coral Laboratories had a gross margin of 58.82% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Coral Laboratories was 52.80%. The lowest was 35.81%. And the median was 38.35%.


Coral Laboratories Gross Profit Historical Data

The historical data trend for Coral Laboratories's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coral Laboratories Gross Profit Chart

Coral Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 252.81 414.69 305.78 286.32 417.54

Coral Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.92 118.76 182.23 166.78 135.21

Competitive Comparison of Coral Laboratories's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Coral Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coral Laboratories's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Coral Laboratories's Gross Profit distribution charts can be found below:

* The bar in red indicates where Coral Laboratories's Gross Profit falls into.


;
;

Coral Laboratories Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Coral Laboratories's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=820.989 - 403.45
=418

Coral Laboratories's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=229.861 - 94.654
=135

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹603 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Coral Laboratories's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=135 / 229.861
=58.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Coral Laboratories  (BOM:524506) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Coral Laboratories had a gross margin of 58.82% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Coral Laboratories Gross Profit Related Terms

Thank you for viewing the detailed overview of Coral Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Coral Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Lal Bahadur Shastri Road, No. 3-B, Patanwala Industrial Estate, Opposite Shreyas Cinema, Ghatkopar (West), Mumbai, MH, IND, 400086
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.

Coral Laboratories Headlines

No Headlines